|
|
|
|
Insulin study could lead to new dosage devices
Buy Maxalt Without a Prescription Buy no Prescription Strattera Order Tamiflu no Prescription Online Buy Medrol Without a Prescription Buy Naltrexone Without a Prescription Buy no Prescription Antabuse Online Buy Boniva no Prescription Buy Propecia Without a...
|
|
|
Mums anguish at breast cancer drug shortage
10:30am Monday 8th February 2010 Exclusive By Nicola Fifield A BREAST cancer patient from York says she is disgusted by a shortage of the drug she and hundreds of other women rely on to reduce the risk of the disease returning.Mother-of-two Marion Barclay,...
|
|
|
FDA Okays Drug Combo for Advanced Breast Cancer
The U.S.Food and Drug Administration (FDA) has approved the combination of the targeted therapy Tykerb (chemical name: lapatinib) and the hormonal therapy Femara (chemical name: letrozole) to treat post-menopausal women diagnosed with hormone-receptor...
|
|
|
Pomegranate compounds may help curb breast cancer risk
else else imgBox.style.width photo.width + else // default it to para14 if no cookie setFontSize(storyfontsize,storyfontimage) name, value, expires, path, domain, secure ) expires_date new Date( + (expires) name + + escape( value ) + ( ( expires )?+ : '' ) +...
|
|
|
Pomegranate compounds may help curb breast cancer risk
Enzyme-blocking chemicals in pomegranates may reduce the risk of estrogen-fueled breast cancers, U.S.researchers said Tuesday. An acid found in pomegranates appears to block aromatase, an enzyme that converts androgen to estrogen, a hormone that plays a...
|
|
|
Pomegranate compounds may help curb breast cancer risk
Enzyme-blocking chemicals in pomegranates may reduce the risk of estrogen-fueled breast cancers, U.S.researchers said Tuesday. An acid found in pomegranates appears to block aromatase, an enzyme that converts androgen to estrogen, a hormone that plays a...
|
|
|
GSK to slash R&D jobs
THE scale of how the recession has cut into high-value research and development jobs in the pharmaceutical industry will be laid bare this week, as job losses in the industry climb to 12,000.GlaxoSmithKline, the British drugs group, will announce plans on...
|
|
|
Research and Markets: Drive the Roadmap for Success in Oncology as Global Oncology Market is Projected to Outg
Research and Markets (http://www.researchandmarkets.com/research/d7939f/roadmap_for_succes) has announced the addition of the 'Roadmap for Success in Oncology' report to their offering.The worldwide oncology market is projected to outgrow the rest of the...
|
|
|
AstraZeneca Job Cuts Continue While Profits Soar
Pharmaceutical giant AstraZeneca will cut its workforce by 16 percent by 2014, even as it continues to show strong growth in its profits.The company reported $31.6 billion in profits last year, an increase of 6.9 percent over last year. AstraZeneca...
|
|
|
Company News: AstraZeneca
More In Business Briefs AstraZeneca announced plans to cut 8,000 jobs -- around 12% of its global workforce -- by 2014 as part of a cost-cutting exercise.The firm, which has already eliminated 12,600 jobs in recent years, will lose US market exclusivity on ...
|
|
|
Drugs companies face deeper cuts in research
The extent to which the recession has cut into high-value research and development jobs in the pharmaceutical industry will be laid bare this week as job losses in the industry climb to 12,000.GlaxoSmithKline (GSK), the British drugs group, will announce...
|
|
|
AZ plans 8,000 job cuts by 2014 and will outsource more R&D
Related topics: Globalisation, Lifecycle management, Industry Drivers, Contract services (outsourcing) AstraZeneca will cut 8,000 more jobs by 2014 with R&D and supply chain operations being the main focus of the cutbacks.The move, detailed in...
|
|
|
AstraZeneca to axe 8 000 more jobs
AstraZeneca plans to axe 8 000 more jobs worldwide by 2014, extending a cost-cutting drive despite soaring profits, the Anglo-Swedish drugmaker announced on Thursday.'Today we have proposed a further reduction in headcount of 8 000,' a spokeswoman told AFP....
|
|
|
AstraZeneca To Layoff 8,000 Workers
LONDON (AP) Pharmaceutical company AstraZeneca PLC plans to ax 8,000 more jobs, or 12 percent of its work force, by 2014 to cut costs as it reported disappointing fourth quarter earnings.The Anglo-Swedish company, which said the job cuts will be made across...
|
|
|
AstraZeneca plans 8,000 job cuts ahead of tough period
David Brennan, chief executive of AstraZeneca, warned yesterday that the company was unlikely to see a notable growth in revenue before 2015 as it loses exclusivity on several key drugs.To meet the challenge, AstraZeneca will revamp its research and...
|
|
|
AstraZeneca to Cut 8,000 Jobs Amid Weak Earnings
JANE WARDELL AP Business Writer LONDON (AP) ' AstraZeneca PLC said Thursday it plans to ax 8,000 more jobs, or 12 percent of its work force, by 2014 to cut costs as it reported disappointing fourth quarter earnings.The Anglo-Swedish company, which said the...
|
|
|
Gloomy AstraZeneca cuts staff
AstraZeneca disappointed the City yesterday with a downbeat forecast for the year as it dispensed some harsh medicine by cutting another 8000 jobs.The giant pharmaceutical company posted fourth-quarter earnings below forecasts but sought to ease pressure on...
|
|
|
Pharma fails to impress
NEW YORK (Reuters) - U.S.drugmakers Bristol-Myers Squibb Co and Eli Lilly and Co said on Thursday they expect 2010 earnings growth in line with Wall Street estimates, but Britain-based AstraZeneca signalled tough sledding ahead as all three gird for patent...
|
|
|
AstraZeneca Falls on Disappointing Forecast, Buyback (Update3)
(Adds closing share price in fifth paragraph.) Jan.28 (Bloomberg) -- AstraZeneca Plc fell the most in more than 10 months in London trading after the U.K. drugmakers sales forecast and stock buyback disappointed some analysts and fourth-quarter profit...
|
|
|
AstraZeneca to shed 8,000 jobs as it farms out more R&D work
AstraZeneca is to cut 8,000 jobs worldwide as it embarks on one of the biggest shake-ups seen in the pharmaceutical industry.Analysts believe that the cuts announced yesterday could lead to the loss of 1,500 jobs in the UK, where AstraZeneca has research and...
|
|
|
AstraZeneca to cut 8,000 jobs as it farms out R&D
AstraZeneca is to cut 8,000 jobs worldwide as it embarks on one of the biggest shake-ups seen in the pharmaceutical industry.Analysts believe that the cuts announced yesterday could lead to the loss of 1,500 jobs in the UK, where AstraZeneca has research and...
|
|
|
AstraZeneca to cut 8,000 jobs amid weak earnings
LONDON --Pharmaceutical company AstraZeneca PLC said Thursday it plans to ax 8,000 more jobs, or 12 percent of its work force, by 2014 to cut costs as it reported disappointing fourth quarter earnings.The Anglo-Swedish company, which said the job cuts will...
|
|
|
AstraZeneca reports strong rise in earnings
LONDON-Pharmaceutical company AstraZeneca PLC said Thursday it plans to ax 8,000 more jobs to cut costs as it reported a 26 percent jump in fourth quarter net profit to $1.56 billion.Full-year net profit surged 23 percent to $7.54 billion after the drugmaker...
|
|
|
AstraZeneca to cut 8,000 jobs amid weak earnings
LONDON_Pharmaceutical company AstraZeneca PLC said Thursday it plans to ax 8,000 more jobs, or 12 percent of its work force, by 2014 to cut costs as it reported disappointing fourth quarter earnings.The Anglo-Swedish company, which said the job cuts will be...
|
|
|
Drugmaker AstraZeneca to axe 8,000 more jobs
LONDON (AFP) - AstraZeneca plans to axe 8,000 more jobs worldwide by 2014, extending a cost-cutting drive despite soaring profits, the Anglo-Swedish drugmaker announced on Thursday."Today we have proposed a further reduction in headcount of 8,000," a...
|
